REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $405,271 | -77.8% | 35,333 | -50.9% | 0.00% | -100.0% |
| Q2 2023 | $1,822,497 | +4.7% | 72,007 | +33.3% | 0.00% | 0.0% |
| Q1 2023 | $1,739,887 | +11.9% | 54,017 | -35.9% | 0.00% | – |
| Q4 2022 | $1,555,015 | -37.7% | 84,237 | -8.9% | 0.00% | -100.0% |
| Q3 2022 | $2,498,000 | +95.6% | 92,505 | +0.2% | 0.00% | – |
| Q2 2022 | $1,277,000 | -36.7% | 92,337 | -10.7% | 0.00% | -100.0% |
| Q1 2022 | $2,017,000 | -27.4% | 103,430 | -39.2% | 0.00% | 0.0% |
| Q4 2021 | $2,779,000 | -79.8% | 170,239 | -65.5% | 0.00% | -66.7% |
| Q3 2021 | $13,746,000 | +13.9% | 493,384 | +21.2% | 0.00% | 0.0% |
| Q2 2021 | $12,064,000 | +2.7% | 407,009 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $11,751,000 | -3.5% | 420,382 | -2.2% | 0.00% | 0.0% |
| Q4 2020 | $12,180,000 | +92.3% | 429,800 | +70.6% | 0.00% | +50.0% |
| Q3 2020 | $6,335,000 | +233.8% | 251,993 | +224.2% | 0.00% | +100.0% |
| Q2 2020 | $1,898,000 | +126.8% | 77,727 | +37.4% | 0.00% | – |
| Q1 2020 | $837,000 | +15.0% | 56,576 | +26.0% | 0.00% | – |
| Q4 2019 | $728,000 | +97.3% | 44,902 | +58.1% | 0.00% | – |
| Q3 2019 | $369,000 | +6.6% | 28,399 | +6.4% | 0.00% | – |
| Q2 2019 | $346,000 | +10.5% | 26,681 | +34.5% | 0.00% | – |
| Q1 2019 | $313,000 | -14.5% | 19,833 | +9.1% | 0.00% | – |
| Q4 2018 | $366,000 | -6.2% | 18,179 | +15.8% | 0.00% | – |
| Q3 2018 | $390,000 | -2.0% | 15,700 | +8.4% | 0.00% | – |
| Q2 2018 | $398,000 | -49.6% | 14,482 | -43.5% | 0.00% | – |
| Q1 2018 | $789,000 | +58.1% | 25,635 | +83.9% | 0.00% | – |
| Q4 2017 | $499,000 | -4.4% | 13,940 | -26.5% | 0.00% | – |
| Q3 2017 | $522,000 | -15.1% | 18,957 | -18.6% | 0.00% | – |
| Q2 2017 | $615,000 | -58.4% | 23,284 | -67.3% | 0.00% | – |
| Q1 2017 | $1,479,000 | -16.7% | 71,148 | -17.1% | 0.00% | -100.0% |
| Q4 2016 | $1,776,000 | +897.8% | 85,780 | +680.7% | 0.00% | – |
| Q3 2016 | $178,000 | +41.3% | 10,987 | +19.1% | 0.00% | – |
| Q2 2016 | $126,000 | -31.5% | 9,228 | -12.3% | 0.00% | – |
| Q1 2016 | $184,000 | -27.3% | 10,519 | +42.3% | 0.00% | – |
| Q4 2015 | $253,000 | -3.1% | 7,393 | -15.6% | 0.00% | – |
| Q3 2015 | $261,000 | +11.5% | 8,760 | +19.7% | 0.00% | – |
| Q2 2015 | $234,000 | +20.6% | 7,318 | -22.1% | 0.00% | – |
| Q1 2015 | $194,000 | +506.2% | 9,396 | +408.7% | 0.00% | – |
| Q4 2014 | $32,000 | -11.1% | 1,847 | +1.8% | 0.00% | – |
| Q3 2014 | $36,000 | -7.7% | 1,814 | +59.4% | 0.00% | – |
| Q2 2014 | $39,000 | – | 1,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |